Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.87 USD | -0.99% | -2.21% | +18.10% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.10% | 3.3B | |
+1.94% | 42.59B | |
+8.39% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.81% | 24.81B | |
-24.22% | 18.17B | |
+28.83% | 12.05B | |
-2.99% | 11.7B | |
+6.99% | 11.1B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Crinetics Pharmaceuticals : JPMorgan Upgrades Crinetics Pharmaceuticals to Overweight From Neutral; Price Target is $28